Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1994 1
1995 1
1997 5
1998 2
1999 3
2000 4
2001 4
2002 2
2003 3
2004 3
2005 4
2006 7
2007 12
2008 9
2009 11
2010 7
2011 4
2012 2
2013 2
2014 1
2015 4
2016 7
2017 14
2018 12
2019 8
2020 6
2021 7
2022 7
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial.
Sartore-Bianchi A, Trusolino L, Martino C, Bencardino K, Lonardi S, Bergamo F, Zagonel V, Leone F, Depetris I, Martinelli E, Troiani T, Ciardiello F, Racca P, Bertotti A, Siravegna G, Torri V, Amatu A, Ghezzi S, Marrapese G, Palmeri L, Valtorta E, Cassingena A, Lauricella C, Vanzulli A, Regge D, Veronese S, Comoglio PM, Bardelli A, Marsoni S, Siena S. Sartore-Bianchi A, et al. Among authors: ghezzi s. Lancet Oncol. 2016 Jun;17(6):738-746. doi: 10.1016/S1470-2045(16)00150-9. Epub 2016 Apr 20. Lancet Oncol. 2016. PMID: 27108243 Free article. Clinical Trial.
Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer.
Patelli G, Mauri G, Tosi F, Amatu A, Bencardino K, Bonazzina E, Pizzutilo EG, Villa F, Calvanese G, Agostara AG, Stabile S, Ghezzi S, Crisafulli G, Di Nicolantonio F, Marsoni S, Bardelli A, Siena S, Sartore-Bianchi A. Patelli G, et al. Among authors: ghezzi s. Clin Cancer Res. 2023 Nov 14;29(22):4530-4539. doi: 10.1158/1078-0432.CCR-23-0079. Clin Cancer Res. 2023. PMID: 37436743 Free PMC article. Review.
Origin and evolution of SARS-CoV-2.
Pagani I, Ghezzi S, Alberti S, Poli G, Vicenzi E. Pagani I, et al. Among authors: ghezzi s. Eur Phys J Plus. 2023;138(2):157. doi: 10.1140/epjp/s13360-023-03719-6. Epub 2023 Feb 16. Eur Phys J Plus. 2023. PMID: 36811098 Free PMC article. Review.
Biobanking for COVID-19 research.
Rovere-Querini P, Tresoldi C, Conte C, Ruggeri A, Ghezzi S, DE Lorenzo R, DI Filippo L, Farina N, Ramirez GA, Ripa M, Mancini N, Cantarelli E, Galli L, Poli A, DE Cobelli F, Bonini C, Manfredi AA, Franchini S, Spessot M, Carlucci M, Dagna L, Scarpellini P, Ambrosio A, DI Napoli D, Bosi E, Tresoldi M, Lazzarin A, Landoni G, Martino G, Zangrillo A, Poli G, Castagna A, Vicenzi E, Clementi M, Ciceri F; COVID-BioB Study Group. Rovere-Querini P, et al. Among authors: ghezzi s. Panminerva Med. 2022 Jun;64(2):244-252. doi: 10.23736/S0031-0808.20.04168-3. Epub 2020 Oct 19. Panminerva Med. 2022. PMID: 33073557
RAGE engagement by SARS-CoV-2 enables monocyte infection and underlies COVID-19 severity.
Angioni R, Bonfanti M, Caporale N, Sánchez-Rodríguez R, Munari F, Savino A, Pasqualato S, Buratto D, Pagani I, Bertoldi N, Zanon C, Ferrari P, Ricciardelli E, Putaggio C, Ghezzi S, Elli F, Rotta L, Scardua A, Weber J, Cecatiello V, Iorio F, Zonta F, Cattelan AM, Vicenzi E, Vannini A, Molon B, Villa CE, Viola A, Testa G. Angioni R, et al. Among authors: ghezzi s. Cell Rep Med. 2023 Nov 21;4(11):101266. doi: 10.1016/j.xcrm.2023.101266. Epub 2023 Nov 8. Cell Rep Med. 2023. PMID: 37944530 Free PMC article.
137 results